Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Ovarian Malignant Mixed Germ Cell Tumor: A Case of Unusual Presentation as Molar Pregnancy

Authors
Gynecology Oncology Department, Iran University of Medical Sciences, Tehran, Iran
Abstract
Background: This research was conducted to introduce a patient with rare ovarian mixed germ cell tumor, presented as molar pregnancy. Case Presentation: The patient was a 16 year old woman admitted with diagnosis of molar pregnancy. Abdominal enlargement was the only complaint. She had a large pelvic mass in physical examination. The first diagnosis was molar pregnancy due to previous ultrasonic reports and positive βeta HCG. Urine pregnancy test was positive. As suction curettage was performed for her, surprisingly, the size of uterus was normal and no molar tissue was found in pathologic examination. At intraoperative ultrasound exam, an extra-uterine heterogeneous mass was found. Extra-uterine mass was confirmed by CT and MRI done after suction curettage. Mixed germ cell tumor was confirmed by histological examination after laparatomy and removing tumoral mass. Finally, she received Bleomycin, Etoposide and Cisplatin (BEP) regimen in four courses and Vincristine, Actinomycin D (Dactinomycin) and Cyclophosphamide (VAC) regimen in two courses and Diphereline for saving the other ovary. Conclusion: Some young patients misinterpret the early symptoms of an ovarian neoplasm as those of pregnancy which can lead to a delay in the diagnosis.
Keywords

  1. Berek JS, Hacker NF. Berek & Hacker’s Gynecologic Oncology. 5th ed. New York: Lippincott Williams & Wilkins; 2009. 912 p.
  2. Goyal LD, Kaur S, Kawatra K. Malignant mixed germ cell tumour of ovary--an unusual combination and review of literature. J Ovarian Res. 2014;7:91.
  3. DiSaia PhJ, Creasman WT. Clinical gynecologic oncology. 8th ed. Elsevier Health Sciences; 2012. 342 p.
  4. Pagaro PM, Gore CR, Patil T, Chandanwale Sh. Mixed germ cell tumors: report of two cases. Med J of Dr. DY Patil Univ. 2013;6(3):298-301.
  5. Kurman RJ, Norris HJ. Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol. 1976;48(5):579-89.
  6. DiSaia Ph J, Creasman WT. Clinical gynecologic oncology. 6th ed. US: Mosby; 2002. 675 p.
  7. Igwegbe A, Eleje G. Hydatidiform mole: A Review of Management Outcomes in a Tertiary Hospital in South-East Nigeria. Ann Med Health Sci Res. 2013;3(2):210-4.
  8. Lazarus E, Hulka C, Siewert B, Levine D. Sonographic appearance of early complete molar pregnancies. J Ultrasound Med. 1999;18(9):589-94.
  9. Aoki Y, Kase H, Fujita K, Tanaka K. Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence. Gynecol Obstet Invest. 2003;55(1):58-60.
  10. Ghaemmaghami F, Modares M, Arab M, Behtash N, Moosavi AZ, Khanafshar N, et al. EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV). Int J Gynecol Cancer. 2004;14(2):360-5.
  11. Berek JS, Hacker NF. Practical Gynecologic Oncology. 3rd ed. UK: Lippinkot Williams and Wilkins; 2000. Chapter 12, Non epithelial ovarian and fallopian tube cancers; p. 523-51.
  12. Huser M, Crha I, Ventruba P, Hudecek R, Zakova J, Smardova L, et al. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod. 2008;23(4):863-8.